International Stem Cell Corporation is Valued at $34 Million Market Value by Edison Investment Research – GlobeNewswire (press release)
Investing.com |
International Stem Cell Corporation is Valued at $34 Million Market Value by Edison Investment Research
GlobeNewswire (press release) CARLSBAD, Calif., May 14, 2018 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (“ISCO” or “the Company”), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical … International Stem Cell: Moving Forward In Parkinson’s And TBIInvesting.com |
|
International Stem Cell Corporation is Valued at $34 Million Market Value by Edison Investment Research
Nasdaq CARLSBAD, Calif., May 14, 2018 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (“ISCO” or “the Company”), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical … International Stem Cell: Moving Forward In Parkinson’s And TBIInvesting.com |
Moneycontrol.com |
A Harvard startup is using gene therapy to reverse ageing in dogs, humans are next
Moneycontrol.com In order to achieve the objective to “have the body and mind of a 22-year-old but the experience of a 130-year-old,” a Harvard professor backed startup is planning to rejuvenate dogs using gene therapy. And, if results are positive, the same approach … Harvard startup aims to reverse aging in dogs, and possibly humansBusiness Insider India Harvard startup aims to ‘reverse aging’ in dogs, humans could be nextTHE WEEK |
Drug Target Review |
CRISPR used to restore retinal function
Drug Target Review Researchers from Columbia University have developed a new technique for the powerful gene editing tool CRISPR to restore retinal function in mice afflicted by a degenerative retinal disease, retinitis pigmentosa. This is the first time researchers have … New technique may help patients overcome various eye diseasesDeccan Chronicle A new ‘vision’The Asian Age |
Herald Sun |
Mini organs grown for stem cell test hoped to cure fatal disease in premature babies
Herald Sun The team’s preclinical studies have shown that amnion cells taken from the placenta can support the bowel’s own stem cells to repair itself. If the team is able to grow and then treat “mini bowels” with stem cells, they would then test whether breast … |